You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Apixaban

Showing 26 - 50 of 463
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cirrhosis, Splenectomy, Venous Thrombosis Trial in Yangzhou (Apixaban 2.5 MG, Dipyridamole 25Mg Tab, subcutaneous Low Molecular

Recruiting
  • Cirrhosis
  • +3 more
  • Apixaban 2.5 MG
  • +2 more
  • Yangzhou, Jiangsu, China
    Clinical Medical College, Yangzhou University
Apr 30, 2022

Safety Outcome in Atrial Fibrillation Treated by Apixaban in

Recruiting
  • Atrial Fibrillation
    • Brussels, Belgium
      Pfizer Site
    Oct 10, 2022

    Intracranial Hemorrhage in Glioma Venous Thromboembolism

    Terminated
    • Glioma, Malignant
    • Observation of ICH and VTE
    • Sacramento, California
    • +1 more
    Aug 5, 2022

    COVID-19 Trial in Rawalpindi (Apixaban, Rivaroxaban)

    Not yet recruiting
    • COVID-19
    • Rawalpindi, Punjab, Pakistan
      Rawalpindi Medical University
    Feb 22, 2022

    Left Ventricular Thrombus Trial in Dammam (Apixaban, Warfarin)

    Completed
    • Left Ventricular Thrombus
    • Dammam, Saudi Arabia
      Saud AlBabtain Cardiac Center
    Jan 12, 2022

    Venous Thromboembolism Trial in Stanford (Apixaban 2.5 MG Oral Tablet, Enoxaparin 40Mg/0.4mL Prefilled Syringe)

    Recruiting
    • Venous Thromboembolism
    • Apixaban 2.5 MG Oral Tablet
    • Enoxaparin 40Mg/0.4mL Prefilled Syringe
    • Stanford, California
      Stanford University Medical Center
    Mar 16, 2022

    Heart Failure Trial in Falls Church (Apixaban, Warfarin, LVAD implant)

    Recruiting
    • Heart Failure
    • Apixaban
    • +2 more
    • Falls Church, Virginia
      Inova Fairfax Medical Campus
    Feb 21, 2022

    Venous Thromboembolism, Deep Venous Thrombosis, Pulmonary Embolism Trial in Canada, United States (Abelacimab, Apixaban)

    Recruiting
    • Venous Thromboembolism
    • +2 more
    • Abelacimab
    • Apixaban
    • Lexington, Kentucky
    • +2 more
    Jun 6, 2022

    Called H2H-OSCAR-US to Learn More About How Well Rivaroxaban

    Active, not recruiting
    • Treatment of Venous Thromboembolism in Cancer Patients
    • +2 more
    • Rivaroxaban (Xarelto, BAY59-7939)
    • Apixaban
    • Wuppertal, Germany
      Bayer
    Jul 25, 2022

    Patterns Among Venous Thromboembolism in the United States

    Active, not recruiting
    • Venous Thromboembolism
    • New York, New York
      Pfizer
    Mar 29, 2023

    (Called RETAF-PS) UsingPatient Survey to Learn More About

    Not yet recruiting
    • Prevention of Thromboembolic Events
    • Atrial Fibrillation
    • Apixaban
    • Whippany, New Jersey
      Bayer
    Jul 21, 2022

    Cirrhosis, Splenectomy; Status, Venous Thrombosis Trial in Yangzhou (Apixaban, Warfarin, Aspirin)

    Recruiting
    • Cirrhosis
    • +3 more
    • Apixaban
    • +4 more
    • Yangzhou, Jiangsu, China
      Clinical Medical College of Yangzhou University
    Mar 19, 2022

    Atrial Fibrillation Trial in Ottawa (Apixaban, Rivaroxaban)

    Recruiting
    • Atrial Fibrillation
    • Ottawa, Ontario, Canada
      The Ottawa Hospital - General Campus
    Mar 14, 2022

    Pancreas Cancer, DVT, Pulmonary Embolism Trial in Philadelphia (Apixaban)

    Completed
    • Pancreas Cancer
    • +2 more
    • Apixaban
    • Philadelphia, Pennsylvania
      Thomas Jefferson University Clinical Research Unit
    Dec 6, 2021

    Venous Thromboembolism Trial in Canada (Apixaban, Rivaroxaban)

    Completed
    • Venous Thromboembolism
    • Edmonton, Alberta, Canada
    • +3 more
    Mar 21, 2022

    Prophylactic and Therapeutic Anticoagulants in Egyptian COVID-19

    Completed
    • Covid19
    • +2 more
    • Cairo, Please Select, Egypt
      Teachers Hospital
    Jul 19, 2022

    Myeloproliferative Tumor, Essential Thrombocythemia, JAK2 Mutation Trial in Ottawa (Apixaban 2.5 MG Oral Tablet [ELIQUIS],

    Recruiting
    • Myeloproliferative Neoplasm
    • +5 more
    • Apixaban 2.5 MG Oral Tablet [ELIQUIS]
    • Aspirin 81 mg
    • Ottawa, Ontario, Canada
      The Ottawa Hospital
    Apr 19, 2022

    Aortic Valve Disease Trial in Paris (Apixaban 5 MG Oral Tablet, warfarin with an objective of INR target of 2.5 (range:

    Not yet recruiting
    • Aortic Valve Disease
    • Apixaban 5 MG Oral Tablet
    • warfarin with an objective of INR target of 2.5 (range: 2.0-3.0)
    • Paris, France
      Service de Cardiologie Hôpital Lariboisière
    Jan 24, 2023

    ELIQUIS Regulatory Post-Marketing Surveillance In Clinical

    Completed
    • Venous Thromboembolism
      • Shinjuku-ku, Tokyo, Japan
        Local Institution
      Feb 3, 2022

      "ORBIT" Versus "HAS-BLED" Scores in Predicting Major Bleeding in

      Not yet recruiting
      • Patients With Atrial Fibrillation Receiving Oral Anticoagulants
      • (no location specified)
      Jul 27, 2023

      Ischemic Stroke, Anticoagulant Adverse Reaction Trial in Taipei (Dabigatran, rivaroxaban, apixaban, edoxaban)

      Recruiting
      • Ischemic Stroke
      • Anticoagulant Adverse Reaction
      • Dabigatran, rivaroxaban, apixaban, edoxaban
      • Taipei, Taiwan
        National Taiwan University Hospital
      Nov 22, 2023

      Transient Ischemic Attack, Stroke, Atrial Fibrillation Trial in United States (Apixaban, Warfarin)

      Completed
      Has Results
      • Transient Ischemic Attack
      • +2 more
      • Torrance, California
      • +4 more
      Nov 3, 2021

      Anti-Xa Activity Trial in Vancouver (apixaban)

      Terminated
      Has Results
      • Anti-Xa Activity
      • apixaban
      • Vancouver, British Columbia, Canada
        Vancouver General Hospital
      Jul 28, 2021

      Nephrotic Syndrome, Thromboembolic Disease Trial in Aarhus (Dalteparin, Apixaban)

      Recruiting
      • Nephrotic Syndrome
      • Thromboembolic Disease
      • Aarhus, Denmark
        Aarhus University Hospital
      May 20, 2022

      Non-Valvular Atrial Fibrillation Patients Using Oral

      Completed
      • Atrial Fibrillation
      • (no location specified)
      May 4, 2022